Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Chemotherapy places patients at an increased risk of infection. A medication called
granulocyte colony-stimulating factor is given as a daily injection in order to help decrease
the risk of infection. The purpose of this study is to determine the best time to begin
granulocyte colony-stimulating factor while maintaining the same clinical benefits. The
current study aims to fill these research gaps and address the general question: Can G-CSF
safely be given 72 hours following the last day of chemotherapy without increasing the
incidence of febrile neutropenia, the duration of neutropenia, or causing increased delays in
the next course of chemotherapy.